These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6106254)

  • 1. Clinical use of the radioreceptor assay for neuroleptics.
    Cohen BM; Lipinski JF; Harris PQ; Pope HG; Friedman M
    Psychiatry Res; 1980 May; 2(2):173-8. PubMed ID: 6106254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
    Krska J; Sampath G; Shah A; Soni SD
    Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
    Tune LE; Creese I; DePaulo JR; Slavney PR; Snyder SH
    J Nerv Ment Dis; 1981 Jan; 169(1):60-3. PubMed ID: 6108981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
    Tune LE; Creese I; Depaulo JR; Slavney PR; Coyle JT; Snyder SH
    Am J Psychiatry; 1980 Feb; 137(2):187-90. PubMed ID: 6101524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the clinical utility of radioreceptor assay in outpatients with schizophrenia receiving high doses of neuroleptics.
    Gagné MA; Cormier H; Leblanc G; Lévesque D; Di Paolo T
    Can J Psychiatry; 1993 Oct; 38(8):534-40. PubMed ID: 7902199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluphenazine blood levels and clinical response.
    Harris PQ; Friedman MJ; Cohen BM; Cooper TB
    Biol Psychiatry; 1982 Oct; 17(10):1123-30. PubMed ID: 7171656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioreceptor assay of neuroleptics in refractory chronic schizophrenic patients.
    Lindenmayer JP; Smith D; Katz I
    J Clin Psychiatry; 1984 Mar; 45(3):117-9. PubMed ID: 6142035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
    Young AS; Faraone SV; Brown WA
    J Clin Psychopharmacol; 1989 Oct; 9(5):361-3. PubMed ID: 2571620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients.
    Kucharski LT; Alexander P; Tune L; Coyle J
    Psychopharmacology (Berl); 1984; 82(3):194-8. PubMed ID: 6144127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radioreceptor assay for neuroleptic drugs in plasma.
    Lader SR
    J Immunoassay; 1980; 1(1):57-75. PubMed ID: 6112242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioreceptor assay of serum neuroleptic concentrations in psychiatric patients.
    Buckley M; Braithwaite R
    Br J Psychiatry; 1986 Sep; 149():384. PubMed ID: 2877706
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic concentrations in schizophrenic patients: measurements by radioreceptor assay and gas chromatography.
    Javaid JI; Davis JM; Dysken MW; Janicak P; Casper R
    Psychopharmacol Bull; 1983; 19(1):72-4. PubMed ID: 6131469
    [No Abstract]   [Full Text] [Related]  

  • 13. On the clinical relevance and methods of quantification of plasma concentrations of neuroleptics.
    Ko GN; Korpi ER; Linnoila M
    J Clin Psychopharmacol; 1985 Oct; 5(5):253-62. PubMed ID: 2864357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics.
    Harris PQ; Brown SJ; Friedman MJ; Bacopoulos NG
    Biol Psychiatry; 1984 Jun; 19(6):849-60. PubMed ID: 6146355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nithsdale schizophrenia surveys. IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels.
    McCreadie RG; Robertson LJ; Wiles DH
    Br J Psychiatry; 1992 Jun; 160():793-9. PubMed ID: 1352165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum effects confound the neuroleptic radioreceptor assay.
    Mailman RB; DeHaven DL; Halpern EA; Lewis MH
    Life Sci; 1984 Mar; 34(11):1057-64. PubMed ID: 6142394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
    Greenberg JS; Brown WA; Laughren TP; Krantz J
    Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic drug level monitoring in psychiatry: focus on radioreceptor assay techniques.
    Tune LE; Coyle JT
    Ther Drug Monit; 1982; 4(1):59-64. PubMed ID: 6122293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between plasma and red blood cell neuroleptic levels, oral dosage, and clinical parameters in a chronic schizophrenic population.
    Dunlop SR; Shea PA; Hendrie HC
    Biol Psychiatry; 1982 Aug; 17(8):929-36. PubMed ID: 6126231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic radioreceptor activity and clinical outcome in schizophrenia.
    Contreras S; Alexander H; Faber R; Bowden C
    J Clin Psychopharmacol; 1987 Apr; 7(2):95-8. PubMed ID: 3584527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.